全文获取类型
收费全文 | 2861篇 |
免费 | 316篇 |
国内免费 | 1篇 |
专业分类
3178篇 |
出版年
2022年 | 25篇 |
2021年 | 38篇 |
2020年 | 28篇 |
2019年 | 25篇 |
2018年 | 36篇 |
2017年 | 42篇 |
2016年 | 77篇 |
2015年 | 107篇 |
2014年 | 138篇 |
2013年 | 161篇 |
2012年 | 164篇 |
2011年 | 181篇 |
2010年 | 131篇 |
2009年 | 119篇 |
2008年 | 132篇 |
2007年 | 129篇 |
2006年 | 151篇 |
2005年 | 134篇 |
2004年 | 119篇 |
2003年 | 106篇 |
2002年 | 93篇 |
2001年 | 58篇 |
2000年 | 56篇 |
1999年 | 40篇 |
1998年 | 27篇 |
1997年 | 35篇 |
1996年 | 25篇 |
1995年 | 19篇 |
1994年 | 25篇 |
1993年 | 22篇 |
1992年 | 40篇 |
1991年 | 42篇 |
1990年 | 34篇 |
1989年 | 30篇 |
1988年 | 38篇 |
1987年 | 32篇 |
1986年 | 24篇 |
1985年 | 29篇 |
1984年 | 32篇 |
1983年 | 38篇 |
1982年 | 23篇 |
1981年 | 27篇 |
1980年 | 26篇 |
1979年 | 20篇 |
1978年 | 18篇 |
1977年 | 24篇 |
1976年 | 20篇 |
1973年 | 22篇 |
1970年 | 19篇 |
1969年 | 20篇 |
排序方式: 共有3178条查询结果,搜索用时 0 毫秒
81.
Wolfgang Horn 《Hydrobiologia》1991,225(1):115-120
Planktonic crustacean biomass as well as structure are important factors influencing water transparency. The significant dependence of the water quality (Secchi depth) on the concentration and the share of the Daphnia biovolume and not on the total Crustacea biovolume in the Saidenbach reservoir indicates that the density of the Crustacea is only a measure of the cleaning performance, if Daphnia dominates. Using the mean size, the influence of the crustacean structure on the Secchi depth can be recorded. If big size categories prevail (like Daphnia) the water transparency is high. The mainly occurrence of little species (Mesocyclops, Bosmina) results in lower Secchi depths. However, a well defined (significant) relationship is being prevented by the different feeding behaviour of the several species. 相似文献
82.
Gerda Neubert Katja von Au Katrin Drossel Andreas Tzschach Denise Horn Renate Nickel Angela M. Kaindl 《Gene》2013
Angelman syndrome is a neurodevelopmental disorder characterized by mental retardation, severe speech disorder, facial dysmorphism, secondary microcephaly, ataxia, seizures, and abnormal behaviors such as easily provoked laughter. It is most frequently caused by a de novo maternal deletion of chromosome 15q11–q13 (about 70–90%), but can also be caused by paternal uniparental disomy of chromosome 15q11–q13 (3–7%), an imprinting defect (2–4%) or in mutations in the ubiquitin protein ligase E3A gene UBE3A mostly leading to frame shift mutation. In addition, for patients with overlapping clinical features (Angelman-like syndrome), mutations in methyl-CpG binding protein 2 gene MECP2 and cyclin-dependent kinase-like 5 gene CDKL5 as well as a microdeletion of 2q23.1 including the methyl-CpG binding domain protein 5 gene MBD5 have been described. Here, we describe a patient who carries a de novo 5 Mb-deletion of chromosome 15q11.2–q13.1 known to be associated with Angelman syndrome and a further, maternally inherited deletion 2q21.3 (~ 364 kb) of unknown significance. In addition to classic features of Angelman syndrome, she presented with severe infections in the first year of life, a symptom that has not been described in patients with Angelman syndrome. The 15q11.2–q13.1 deletion contains genes critical for Prader–Willi syndrome, the Angelman syndrome causing genes UBE3A and ATP10A/C, and several non-imprinted genes: GABRB3 and GABRA5 (both encoding subunits of GABA A receptor), GOLGA6L2, HERC2 and OCA2 (associated with oculocutaneous albinism II). The deletion 2q21.3 includes exons of the genes RAB3GAP1 (associated with Warburg Micro syndrome) and ZRANB3 (not disease-associated). Despite the normal phenotype of the mother, the relevance of the 2q21.3 microdeletion for the phenotype of the patient cannot be excluded, and further case reports will need to address this point. 相似文献
83.
Trentini Giulia E. Rojas Makarena Gajardo Daniela Alburquenque Débora Villagra Evelyn Gómez Aleydis Arru Laura Arencibia Ariel D. 《Plant Cell, Tissue and Organ Culture》2021,146(3):607-619
Plant Cell, Tissue and Organ Culture (PCTOC) - A biotechnological system for the production of plants biomass and phenylpropanoids of maqui was developed in photomixotrophic TIBs. The in vitro... 相似文献
84.
85.
Gomez-Cambronero J Horn J Paul CC Baumann MA 《Journal of immunology (Baltimore, Md. : 1950)》2003,171(12):6846-6855
GM-CSF stimulates proliferation of myeloid precursors in bone marrow and primes mature leukocytes for enhanced functionality. We demonstrate that GM-CSF is a powerful chemotactic and chemokinetic agent for human neutrophils. GM-CSF-induced chemotaxis is time dependent and is specifically neutralized with Abs directed to either the ligand itself or its receptor. Maximal chemotactic response was achieved at approximately 7 nM GM-CSF, and the EC(50) was approximately 0.9 nM. Both concentrations are similar to the effective concentrations of IL-8 and less than the effective concentrations of other neutrophil chemoattractants such as neutrophil-activating peptide-78, granulocyte chemotactic protein-2, leukotriene B(4), and FMLP. GM-CSF also acts as a chemoattractant for native cells bearing the GM-CSF receptor, such as monocytes, as well as for GM-CSF receptor-bearing myeloid cell lines, HL60 (promyelomonocyte leukemic cell line) and MPD (myeloproliferative disorder cell line), following differentiation induction. GM-CSF induced a rapid, transient increase in F-actin polymerization and the formation of focal contact rings in neutrophils, which are prerequisites for cell migration. The mechanism of GM-CSF-induced chemotaxis appears to involve the cell signaling molecule, ribosomal p70 S6 kinase (p70S6K). Both p70S6K enzymatic activity and T(421)/S(424) and T(389) phosphorylation are markedly increased with GM-CSF. In addition, the p70S6K inhibitor hamartin transduced into cells as active protein, interfered with GM-CSF-dependent migration, and attenuated p70S6K phosphorylation. These data indicate that GM-CSF exhibits chemotactic functionality and suggest new avenues for the investigation of the molecular basis of chemotaxis as it relates to inflammation and tissue injury. 相似文献
86.
87.
Evelyn Walenta Ariane R. Pessentheiner Helmut J. Pelzmann Alexander Deutsch Madeleine Goeritzer Dagmar Kratky Hubert Hackl Da Young Oh Andreas Prokesch Juliane G. Bogner-Strauss 《PloS one》2013,8(11)
Our knowledge about adipocyte metabolism and development is steadily growing, yet many players are still undefined. Here, we show that α/β-hydrolase domain containing protein 15 (Abhd15) is a direct and functional target gene of peroxisome proliferator-activated receptor gamma (PPARγ), the master regulator of adipogenesis. In line, Abhd15 is mainly expressed in brown and white adipose tissue and strongly upregulated during adipogenesis in various murine and human cell lines. Stable knockdown of Abhd15 in 3T3-L1 cells evokes a striking differentiation defect, as evidenced by low lipid accumulation and decreased expression of adipocyte marker genes. In preconfluent cells, knockdown of Abhd15 leads to impaired proliferation, which is caused by apoptosis, as we see an increased SubG1 peak, caspase 3/7 activity, and BAX protein expression as well as a reduction in anti-apoptotic BCL-2 protein. Furthermore, apoptosis-inducing amounts of palmitic acid evoke a massive increase of Abhd15 expression, proposing an apoptosis-protecting role for ABHD15. On the other hand, in mature adipocytes physiological (i.e. non-apoptotic) concentrations of palmitic acid down-regulate Abhd15 expression. Accordingly, we found that the expression of Abhd15 in adipose tissue is reduced in physiological situations with high free fatty acid levels, like high-fat diet, fasting, and aging as well as in genetically obese mice. Collectively, our results position ABHD15 as an essential component in the development of adipocytes as well as in apoptosis, thereby connecting two substantial factors in the regulation of adipocyte number and size. Together with its intricate regulation by free fatty acids, ABHD15 might be an intriguing new target in obesity and diabetes research. 相似文献
88.
M. Chartrain G. Hunt L. Horn A. Kirpekar D. Mathre A. Powell L. Wassel J. Nielsen B. Buckland R. Greasham 《Journal of industrial microbiology & biotechnology》1991,7(4):293-299
Summary An efrotomycin fermentation was characterized through physical, chemical and biochemical studies. Growth of the actinomycete,Nocardia lactamdurans occurred during the first 50 h of the fermentation cycle at the expense of glucose, protein, and triglycerides. The initiation of efrotomycin biosynthesis was observed when glucose dropped to a low concentration. Upon glucose depletion, cell growth ceased and a switch in the respiratory quotient occurred. Efrotomycin biosynthesis was supported by the utilization of soybean oil and starch. Analysis of triglyceride metabolism showed that no diglycerides or monoglycerides accumulated during the fermentation. The activity of extracellular enzymes (lipase, protease, and amylase) increase during the cell growth phase and decreased significantly after 150 h. The concentrations of DNA, tetrahydro-vitamin K2 (a membrane component), and free amino acids in the supernatant increased dramatically late in the fermentation cycle (225 h), indicating massive cell lysis. During this same time period, a reduction in cellular respiratory activity and efrotomycin biosynthesis were observed. 相似文献
89.
Konyukh M Delorme R Chaste P Leblond C Lemière N Nygren G Anckarsäter H Rastam M Ståhlberg O Amsellem F Gillberg IC Mouren-Simeoni MC Herbrecht E Fauchereau F Toro R Gillberg C Leboyer M Bourgeron T 《PloS one》2011,6(3):e17289
Background
Autism spectrum disorders (ASD) are a group of severe childhood neurodevelopmental disorders with still unknown etiology. One of the most frequently reported associations is the presence of recurrent de novo or inherited microdeletions and microduplications on chromosome 16p11.2. The analysis of rare variations of 8 candidate genes among the 27 genes located in this region suggested SEZ6L2 as a compelling candidate.Methodology/Principal Findings
We further explored the role of SEZ6L2 variations by screening its coding part in a group of 452 individuals, including 170 patients with ASD and 282 individuals from different ethnic backgrounds of the Human Genome Diversity Panel (HGDP), complementing the previously reported screening. We detected 7 previously unidentified non-synonymous variations of SEZ6L2 in ASD patients. We also identified 6 non-synonymous variations present only in HGDP. When we merged our results with the previously published, no enrichment of non-synonymous variation in SEZ6L2 was observed in the ASD group compared with controls.Conclusions/Significance
Our results provide an extensive ascertainment of the genetic variability of SEZ6L2 in human populations and do not support a major role for SEZ6L2 sequence variations in the susceptibility to ASD. 相似文献90.
Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults.
Zurina Cinza Estévez Arístides Aguilar Betancourt Verena Muzio González Nelvis Figueroa Baile Carmen Valenzuela Silva Francisco Hernández Bernal Eduardo Pentón Arias Aurora Delhanty Fernández Nelia Martin Olazábal Amaurys del Río Martín Lester Leal Batista Gloria Véliz Ríos Héctor Hernández Hernández Aracelis Blanco Hernández Evelyn Pérez Lugo Joel de la Torre Cruz Bertha L Batista Marchec Leovaldo Alvarez Falcón Jannet Trujillo Brito Darién Ortega León Pedro López Saura 《Biologicals》2007,35(2):115-122
Manufactures of biotechnological/biological products (including vaccines) frequently make changes to manufacturing processes of products both during development and after approval. In our case, a non-inferiority bridging study was carried out to demonstrate that changes in the production plant facilities of Cuban recombinant hepatitis B vaccine, Heberbiovac HB, did not affect the safety and immunogenicity of the vaccine. This controlled, randomized, doubled-blinded trial included 501 volunteers, aged between 20 and 64, who were given three doses of vaccine (20 microg HBsAg/mL) at month 0, 1, and 2. Four lots were evaluated (three corresponding to the new production facilities and a control one produced in the older facilities). One month after the third dose, were observed protective levels of anti-HBsAg in 97% of the subjects that concluded the study with a geometric mean antibody titer (GMT) of 931.18 IU/L. Normal values of body mass index (BMI), the younger ages, and being a female, were significantly related to a good antibody response. The vaccine was well tolerated. Pain at the injection site was the most commonly reported symptom. We conclude that Heberbiovac HB vaccine maintains its characteristics after the modifications carried out in the production plant facilities and both, lot obtained in previous facilities and in the new ones, are comparable in terms of safety and immunogenicity. 相似文献